BioLineRx Ltd. (BLRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioLineRx Ltd.

    NASDAQ: BLRX · Real-Time Price · USD
    3.84
    0.05 (1.32%)
    At close: Sep 26, 2025, 3:59 PM
    3.85
    0.26%
    After-hours: Sep 26, 2025, 06:31 PM EDT

    BioLineRx Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 10.44M 4.25M 10.59M 12.99M
    Short-Term Investments
    		 9.13M 38.74M 40.49M 44.15M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a
    Receivables
    		 3.86M 708K 721K 142K
    Inventory
    		 3.15M 1.95M 197.08K 126.73K
    Other Current Assets
    		 n/a 480K -197.08K -126.73K
    Total Current Assets
    		 27.1M 47.18M 52M 57.4M
    Property-Plant & Equipment
    		 1.35M 1.89M 2.5M 2.28M
    Goodwill & Intangibles
    		 10.45M 14.85M 21.89M 21.7M
    Total Long-Term Assets
    		 11.8M 16.74M 24.38M 23.99M
    Total Assets
    		 38.91M 63.92M 76.38M 81.39M
    Account Payables
    		 5.58M 10.87M 6.97M 5.57M
    Deferred Revenue
    		 n/a 12.96M n/a n/a
    Short-Term Debt
    		 4.48M 3.15M 1.54M 2.76M
    Other Current Liabilities
    		 2.12M 12.35M 84K 2K
    Total Current Liabilities
    		 15.41M 42.78M 10.68M 9.72M
    Long-Term Debt
    		 8.96M 6.63M 8.63M n/a
    Other Long-Term Liabilities
    		 n/a 11.93M 4.51M 1.86M
    Total Long-Term Liabilities
    		 10.04M 19.85M 14.86M 3.58M
    Total Liabilities
    		 25.45M 50.7M 25.54M 13.3M
    Total Debt
    		 15.04M 11.59M 12.32M 4.65M
    Book Value
    		 13.46M 13.22M 50.84M 68.09M
    Book Value Per Share
    		 0.17 0.21 0.99 1.54
    Common Stock
    		 38.1M 31.36M 27.1M 21.07M
    Retained Earnings
    		 -399.83M -390.61M -329.99M -305.04M
    Comprehensive Income
    		 16.13M 16.99M 14.76M 12.72M
    Shareholders Equity
    		 13.46M 13.22M 50.84M 68.09M
    Total Investments
    		 9.13M 38.74M 40.49M 44.15M

    Add to Watchlist